Consistent with our expectations, the Multidistrict Litigation, or MDL, Zantac ruling dismissed cases claiming the drug caused cancer. While we don’t expect any changes to our fair value estimates for ...
The Delaware Supreme Court has overturned a lower court’s decision that allowed expert testimony supporting plaintiffs’ claims in a high-profile case alleging that Zantac, or its generic ranitidine, ...
On May 23, the first verdict in the nation over Zantac came out in Illinois, while a Delaware judge's May 31 decision allowed plaintiffs' experts for thousands of cases. Jurors in Chicago’s Cook ...
PHILADELPHIA, Jan. 17, 2025 /PRNewswire/ -- Legal-Bay LLC, a leading pre settlement funding company, reports that November's $2.2 billion ruling against GlaxoSmithKline has still not been distributed ...
Following a string of legal wins this year—plus one major setback in May—GSK has washed its hands of yet another lawsuit alleging the once-popular heartburn med Zantac can cause cancer. GSK revealed ...
Earlier this week, GSK plc (NYSE:GSK) reached agreements with ten plaintiff firms representing approximately 80,000 Zantac product liability cases in the U.S. state courts. These cases account for 93% ...
Jan 22 (Reuters) - GSK (GSK.L), opens new tab, Pfizer (PFE.N), opens new tab and other pharmaceutical companies are urging a judge in Delaware this week to find that evidence plaintiffs' lawyers want ...
NEW YORK, April 3 (Reuters) - Sanofi (SASY.PA), opens new tab has reached an agreement in principle to settle 4,000 U.S. lawsuits linking the discontinued heartburn drug Zantac to cancer, the company ...
Consistent with our expectations, the Multidistrict Litigation, or MDL, Zantac ruling dismissed cases claiming the drug caused cancer. While we don't expect any changes to our fair value estimates for ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results